Nianyang Ding
Overview
Explore the profile of Nianyang Ding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin Y, Peng Q, Ma L, Dong Y, Sun Y, Xu S, et al.
Qual Life Res
. 2023 Dec;
33(3):753-765.
PMID: 38079024
Purpose: Quality-adjusted life-year (QALY) is a dominant measurement of health gain in economic evaluations for pricing drugs. However, end-of-life (EoL) patients' preference for QALY gains in life expectancy (LE) and...
2.
Bai Z, Ding N, Ge J, Wang Y, Wang L, Wu N, et al.
Cell Biol Int
. 2020 Oct;
45(1):177-187.
PMID: 33049093
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies, and the occurrence of drug-resistance severely limits the efficacy of anticancer drugs in the treatment of NSCLC. Identification of...
3.
Bai Z, Liu X, Guan Q, Ding N, Wei Q, Tong B, et al.
Chem Biol Interact
. 2019 Nov;
315:108886.
PMID: 31682804
Colorectal cancer (CRC) is one of the most common malignancies, and multidrug resistance (MDR) reduces the efficiency of anticancer drugs. Therefore, the development of novel anticancer drugs that are highly...